Back to Main

Faculty Detail    
Name HUMA FATIMA
  
Campus Address HSB 137 Zip 6823
Phone  (205) 934-6160
E-mail  hfatima@uabmc.edu
Other websites
     

Education
Undergraduate  F.G. College for Women, F-7/2, Islamabad    1989  F.SC 
Medical School  Rawalpindi Medical College, Rawalpindi, Pakistan    1995  MBBS 
Residency  University of Toledo Program, Toledo, OH    2006  AP/CP Residency 
Fellowship  William Beaumont Hospital, Royal Oak, MI    2007  Cytopathology Fellowship 
Fellowship  Vanderbilt University, Nashville, TN    2011  Renal Pathology Fellowship 

Certifications
Anatomic Pathology & Clinical Pathology, American Board of Pathology, Inc.  2006 
Cytopathology, American Board of Pathology, Inc.  2010 
Combined AP/CP &Cytopathology Recertification.  2016 


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Clinical Pathology  Anatomic Pathology Associate Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Associate Professor

Biographical Sketch 
Dr. Fatima was born and raised in Pakistan. She received her MBBS degree from Rawalpindi Medical College, Rawalpindi, Pakistan and was an officer in medicine and surgery, 6 months each, in Pakistan. Afterwards, she came to the United States to complete her residency in pathology at the University of Toledo, Toledo Ohio (2002-2006) followed by fellowships in cytology (2006-2007) at William Beaumont Hospital, Royal Oak, MI and renal pathology (2009-2011) at Vanderbilt University, Nashville, TN. During her pathology residency, she was elected to Alpha Omega Alpha, the national medical honor society. She joined the Department of Pathology at the University of Alabama at Birmingham in 2011, following being certified by the Anatomic Board of Pathology, Inc. In Anatomic Pathology and Clinical Pathology with added qualification in Cytopathology.



Research/Clinical Interest
Title
Description
Dr. Fatima is working on the role of activated parietal epithelial cells in the pathogenesis of focal and segmental glomerulosclerosis and their role in arterionephrosclerosis in APOL-1 high risk variants among African Americans. In addition, She is a part of CureGN working group: Biomarker Discovery/Validation/Characterization. CureGN is a NIH funded multi-institutional study that will improve understanding of pathogenesis of primary glomerular diseases and improve the quality of care and life for patients with these glomerular diseases.

Selected Publications 
Publication PUBMEDID
Inman, M., Prater, G., Fatima, H. and Eric Wallace. Eculizumab induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis. Exceptional case. Clinical Kidney Journal, 2015 Aug; 8(4): 445–448. doi: 10.1093/ckj/sfv044   
Wallace, E., Fatima, H., Jackson, L and Warnock, D. Appendiceal tissue confirmation of Fabry’s disease. Kidney International (2015) 88, 417; doi:10.1038/ki.2014.399   
Wallace, E., Maillard, N., Ueda, H., Hall, S., Fatima, H., Novak, J., and Julian, B. Immune profile of IgA-dominant diffuse proliferative glomerulonephritis. Exceptional Case. Clin Kidney J (2014) 7: 1–5 (doi: 10.1093/ckj/sfu090)   
Wallace, E., Lyndon, W., Chumley, P., Jaimes, E A., and Fatima, H. Dasatinib-Induced Nephrotic-Range Proteinuria - Kidney Biopsy Teaching Case. Am J Kidney Dis. 2013;61(6):1026-1031   
Dash, A., Fatima, H., Grewal, M., Galphin, C., and Paueksakon, P.: Renal injury due to anti-glomerular basement membrane antibody-mediated glomerulonephritis without circulating antibody. Clin Kidney J 5(6):591-594, 2012. Doi: 10.1093/ckj/sfs106.

Dwyer, J.P., Fatima, H., Paueksakon, P., and Siew, E.D.: Membranous glomerulopathy with superimposed pauci-immune necrotizing crescentic glomerulonephritis. Clin Kidney J 5(6)587-590, 2012. Doi: 10.1093ckj/sfs145.

Fatima, H., Alpers, C.E., D'Agati, V.D., Fogo, A.B., Moeller, M.J., Smeets, B., and Yang, H.C.,: Parietal Epithelial Cell Activation Marker in Early Recurrence of FSGS in the Transplant. Clin J Am Soc Nephrol 7(11):1852-1858, 2012. Doi: 10.2215/CJN.10571011.

Fatima, H.,: Acute kidney injury associated with spice use: a new clinical entity.CJASN ePress. Clin J Am Soc Nephrol, 2012. Doi: 10.2215/CJN.05690612. 		  
 

Keywords
renal pathology, cytopathology